Delivery Order SPE2DB25D3020-SPE2DB25FWJTS
Award Date 7/30/25
Potential Completion Date 7/31/25
Potential Value $3.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $9,334.98 by the Defense Logistics Agency (DLA) on September 10, 2025, for the supply of RINVOQ ER 15 mg tablets in quantities of 30s. The contract is a firm fixed-price delivery order with an ultimate completion date of September 11, 2025, and was competitively awarded with no set-aside designation. This award represents a child contract under AmerisourceBergen's broader relationship...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on July 30, 2025, for the supply of RINVOQ ER 15 mg tablets (30-count unit dose) valued at $11,415.23. This firm fixed-price contract award was competitively procured with no set-aside designation and carries an ultimate completion date of July 31, 2025. The delivery order is funded through the Defense Logistics Agency's Medical Supply Chain, which procures...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 3, 2025, valued at $91,328.55 for RINVOQ ER 15 mg tablets (30-count units) under a firm fixed price contract type. The award, issued by the Defense Logistics Agency (DLA), was competitively awarded with no set-aside designation and has an ultimate completion date of September 4, 2025. This delivery order serves as a child contract under...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a $3,700.62 delivery order by the Defense Logistics Agency on September 17, 2025, for the supply of RINVOQ ER 15 mg tablets (30-count unit dose packages). The contract represents a firm fixed-price, non-competitive set-aside delivery order with an ultimate completion date of September 18, 2025. This award was issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $14,917.09 for RINVOQ ER 30 MG Tablet (UU 30s) by the Defense Logistics Agency Medical Supply Chain. The contract, awarded on July 22, 2025, with an ultimate completion date of July 23, 2025, utilizes firm fixed pricing and is classified as a non-set-aside competitive award. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order contract from the Defense Logistics Agency (DLA) on September 18, 2025, valued at $16,823.38 for RINVOQ ER 15 mg tablets (30-count units). This firm fixed-price delivery order was competitively awarded with no set-aside designation and carries an ultimate completion date of September 19, 2025. The award is issued as a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $26,154.99 to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of RINVOQ ER 30 mg tablets (quantity: 30-unit bottles). This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of July 23, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $56,620.53 for RINVOQ ER 15 mg tablets (30-count unit of use packaging) by the Medical Supply Chain, a defense agency division. The contract, awarded on September 15, 2025, with an ultimate completion date of September 16, 2025, is structured as a firm fixed price delivery order with no set-aside designation. This award represents a competitive...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $17,605.35 on August 20, 2025, for the supply of RINVOQ ER 30 mg tablets (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 21, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is a child contract...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $3,171.06 on April 22, 2025, for the supply of RINVOQ ER 30 mg tablets (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation, with performance to be completed by April 23, 2025, and fulfillment based in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...